Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Return on Equity (2016 - 2025)

Mimedx (MDXG) has disclosed Return on Equity for 15 consecutive years, with 0.0% as the latest value for Q2 2025.

  • Quarterly Return on Equity fell 1.0% to 0.0% in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Jun 2025, down 1.0% year-over-year, with the annual reading at 0.0% for FY2024, 15.0% up from the prior year.
  • Return on Equity hit 0.0% in Q2 2025 for Mimedx, down from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 12.89% in Q1 2021 to a low of 0.13% in Q4 2023.
  • Historically, Return on Equity has averaged 2.12% across 5 years, with a median of 0.66% in 2023.
  • Biggest five-year swings in Return on Equity: surged 1342bps in 2021 and later tumbled -897bps in 2022.
  • Year by year, Return on Equity stood at 4.3% in 2021, then tumbled by -75bps to 1.06% in 2022, then tumbled by -112bps to 0.13% in 2023, then skyrocketed by 102bps to 0.0% in 2024, then plummeted by -54bps to 0.0% in 2025.
  • Business Quant data shows Return on Equity for MDXG at 0.0% in Q2 2025, 0.0% in Q1 2025, and 0.0% in Q4 2024.